Last 12 months
Inside the activity.
0 purchase rows · 61 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 1 |
| Jan 2026 | 0 | 12 |
| Feb 2026 | 0 | 4 |
| Mar 2026 | 0 | 6 |
| Apr 2026 | 0 | 5 |
| May 2026 | 0 | 4 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 5 |
| Aug 2026 | 0 | 7 |
| Sep 2026 | 0 | 11 |
| Oct 2026 | 0 | 3 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 03, 2017 Filed Mar 7, 2017 23:48 UTC |
ORBIMED ADVISORS LLCDirector
OrbiMed Capital GP III LLCDirector
ISALY SAMUEL DDirector
|
SaleCommon Stock, par value $0.01 per share | 526 | $47.05 | $24,748.30 |
DisclosureSEC source: 0000947871-17-000198 · ss33905_4.xml · nonDerivative · entry 2 ORBIMED ADVISORS LLC · CIK 0001055951 · Director OrbiMed Capital GP III LLC · CIK 0001432241 · Director ISALY SAMUEL D · CIK 0001055949 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 20,044 F1 · price: The price reported in Column 4 is a weighted average price. These shares of the Issuer's common stock ("Shares") were sold in multiple transactions at prices ranging from $47.00 to $47.13 inclusive. Upon request, the Reporting Persons undertake to provide the Issuer, any security holder of the Issuer, or the Securities and Exchange Commission (the "SEC") full information regarding the Shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These shares are held of record by OrbiMed Associates III, LP ("Associates III"). Advisors is the general partner of Associates III. Isaly is the managing member of and owner of a controlling interest in Advisors. By virtue of such relationships, Advisors and Isaly may be deemed to have voting and investment power over the securities held by Associates III and as a result may be deemed to have beneficial ownership over such securities. F4 · ownership.nature: This report on Form 4 is jointly filed by GP III, Advisors, and Isaly. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its or his pecuniary interest therein, if any. The Reporting Persons have designated a representative, currently Jonathan T. Silverstein, a member of Advisors, to serve on the Issuer's board of directors. This report shall not be deemed an admission that any of the Reporting Persons is a beneficial owner for the purpose of Section 16 of the Exchange Act, or for any other purpose. Read SEC document |
| March 03, 2017 Filed Mar 7, 2017 23:48 UTC |
ORBIMED ADVISORS LLCDirector
OrbiMed Capital GP III LLCDirector
ISALY SAMUEL DDirector
|
SaleCommon Stock, par value $0.01 per share | 55,246 | $47.05 | $2,599,324.30 |
DisclosureSEC source: 0000947871-17-000198 · ss33905_4.xml · nonDerivative · entry 1 ORBIMED ADVISORS LLC · CIK 0001055951 · Director OrbiMed Capital GP III LLC · CIK 0001432241 · Director ISALY SAMUEL D · CIK 0001055949 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 2,104,184 F1 · price: The price reported in Column 4 is a weighted average price. These shares of the Issuer's common stock ("Shares") were sold in multiple transactions at prices ranging from $47.00 to $47.13 inclusive. Upon request, the Reporting Persons undertake to provide the Issuer, any security holder of the Issuer, or the Securities and Exchange Commission (the "SEC") full information regarding the Shares sold at each separate price within the range set forth in this footnote. F2 · ownership.nature: These shares are held of record by OrbiMed Private Investments III, LP ("OPI III"). OrbiMed Capital GP III LLC ("GP III") is the general partner of OPI III, and OrbiMed Advisors LLC ("Advisors") is the managing member of GP III. Samuel D. Isaly ("Isaly"), a natural person, is the managing member of and owner of a controlling interest in Advisors. By virtue of such relationships, GP III, Advisors and Isaly may be deemed to have voting and investment power over the securities held by OPI III and as a result may be deemed to have beneficial ownership over such securities. F4 · ownership.nature: This report on Form 4 is jointly filed by GP III, Advisors, and Isaly. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its or his pecuniary interest therein, if any. The Reporting Persons have designated a representative, currently Jonathan T. Silverstein, a member of Advisors, to serve on the Issuer's board of directors. This report shall not be deemed an admission that any of the Reporting Persons is a beneficial owner for the purpose of Section 16 of the Exchange Act, or for any other purpose. Read SEC document |
| March 03, 2017 Filed Mar 7, 2017 18:52 UTC |
SILVERSTEIN JONATHANDirector
|
SaleCommon Stock, par value $0.01 per share | 526 | $47.05 | $24,748.30 |
DisclosureSEC source: 0000947871-17-000199 · ss33906_4.xml · nonDerivative · entry 2 SILVERSTEIN JONATHAN · CIK 0001171005 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 20,044 F1 · price: The price reported in Column 4 is a weighted average price. These shares of the Issuer's common stock ("Shares") were sold in multiple transactions at prices ranging from $47.00 to $47.13 inclusive. Upon request, the Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Securities and Exchange Commission (the "SEC") full information regarding the Shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: These securities are held of record by OrbiMed Associates III, LP ("Associates III") and may be deemed to be indirectly beneficially owned by Advisors and Isaly. Advisors is the sole general partner of Associates III. Isaly is the managing member of, and holder of a controlling interest in, Advisors. By virtue of such relationship, Advisors and Isaly may be deemed to have voting and investment power with respect to the securities held by Associates III noted above. As a result, each of Advisors and Isaly may be deemed to have beneficial ownership of the securities held by Associates III. F4 · ownership.nature: Each of the Reporting Person, GP III, Advisors, and Isaly disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act, as amended (the "Exchange Act"), except to the extent of its or his pecuniary interest therein, if any. This report shall not be deemed an admission that any such entity or person, including the Reporting Person, is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose. Read SEC document |
| March 03, 2017 Filed Mar 7, 2017 18:52 UTC |
SILVERSTEIN JONATHANDirector
|
SaleCommon Stock, par value $0.01 per share | 55,246 | $47.05 | $2,599,324.30 |
DisclosureSEC source: 0000947871-17-000199 · ss33906_4.xml · nonDerivative · entry 1 SILVERSTEIN JONATHAN · CIK 0001171005 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 2,104,184 F1 · price: The price reported in Column 4 is a weighted average price. These shares of the Issuer's common stock ("Shares") were sold in multiple transactions at prices ranging from $47.00 to $47.13 inclusive. Upon request, the Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Securities and Exchange Commission (the "SEC") full information regarding the Shares sold at each separate price within the range set forth in this footnote. F2 · ownership.nature: These securities are held of record by OrbiMed Private Investments III, LP ("OPI III") and may be deemed to be indirectly beneficially owned by OrbiMed Capital GP III LLC ("GP III"), OrbiMed Advisors LLC ("Advisors") and Samuel D. Isaly ("Isaly"). GP III is the sole general partner of OPI III. Advisors, a registered adviser under the Investment Advisers Act of 1940, as amended, is the sole managing member of GP III. By virtue of such relationships, GP III and Advisors may be deemed to have voting and investment power with respect to the securities held by OPI III noted above. The Reporting Person is a member of Advisors. F4 · ownership.nature: Each of the Reporting Person, GP III, Advisors, and Isaly disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act, as amended (the "Exchange Act"), except to the extent of its or his pecuniary interest therein, if any. This report shall not be deemed an admission that any such entity or person, including the Reporting Person, is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose. Read SEC document |
| February 02, 2017 Filed Feb 3, 2017 21:11 UTC |
Burns Thomas WilliamDirector · Chief Executive Officer
|
SaleCommon Stock | 50,000 | $42.58 | $2,129,000.00 |
DisclosureSEC source: 0001562180-17-000485 · primarydocument.xml · nonDerivative · entry 1 Burns Thomas William · CIK 0001644557 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Through the Burns Family Trust Disclosed balance after: 210,240 F1 · kind: These trades were made pursuant to a Rule 10b5-1 trading plan with pre-determined share amounts and prices. F2 · price: This transaction was executed in multiple trades at prices ranging from $42.50 to $42.76. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 13, 2017 Filed Jan 13, 2017 17:04 UTC |
HARRISON RICHARD LCFO & Treasurer
|
Exercise / conversionStock Option (right to buy) · Derivative | 6,313 | $0.00 Strike: $7.28 | $0.00 |
DisclosureSEC source: 0001562180-17-000238 · primarydocument.xml · derivative · entry 7 HARRISON RICHARD L · CIK 0001186724 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,500 Underlying: Common Stock · 6,313 shares Expires 2024-07-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option has a four-year vesting schedule in which 25% vests on the first year anniversary date of the grant and the remainder vests equally for 36 months thereafter, such that the stock option vests in full on the four-year anniversary of the grant date. Read SEC document |
| January 13, 2017 Filed Jan 13, 2017 17:04 UTC |
HARRISON RICHARD LCFO & Treasurer
|
SaleCommon Stock | 6,313 | $40.01 | $252,583.13 |
DisclosureSEC source: 0001562180-17-000238 · primarydocument.xml · nonDerivative · entry 4 HARRISON RICHARD L · CIK 0001186724 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,388 F1 · kind: These trades were made pursuant to a Rule 10b5-1 trading plan with pre-determined share amounts and prices. F3 · price: This transaction was executed in multiple trades at prices ranging from $40.00 to $40.15. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 13, 2017 Filed Jan 13, 2017 17:04 UTC |
HARRISON RICHARD LCFO & Treasurer
|
Exercise / conversionCommon Stock | 6,313 | $7.28 | $45,927.08 |
DisclosureSEC source: 0001562180-17-000238 · primarydocument.xml · nonDerivative · entry 3 HARRISON RICHARD L · CIK 0001186724 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,701 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These trades were made pursuant to a Rule 10b5-1 trading plan with pre-determined share amounts and prices. Read SEC document |
| January 13, 2017 Filed Jan 13, 2017 22:04 UTC |
Calcaterra Chris M.Chief Commercial Officer
|
Exercise / conversionStock Options (Right to buy) · Derivative | 3,723 | $0.00 Strike: $7.28 | $0.00 |
DisclosureSEC source: 0001562180-17-000237 · primarydocument.xml · derivative · entry 6 Calcaterra Chris M. · CIK 0001640771 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,723 shares Expires 2024-07-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option, which represented the right to purchase a total of 110,000 shares, has a two-year vesting schedule in which 75% vested on July 10, 2015, the first anniversary of the grant date, and the remainder vested equally for 12 months thereafter, such that the stock option vested in full on July 31, 2016, the second anniversary of the grant date. Read SEC document |
| January 13, 2017 Filed Jan 13, 2017 22:04 UTC |
Calcaterra Chris M.Chief Commercial Officer
|
SaleCommon Stock | 3,723 | $40.03 | $149,031.69 |
DisclosureSEC source: 0001562180-17-000237 · primarydocument.xml · nonDerivative · entry 4 Calcaterra Chris M. · CIK 0001640771 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 240,000 F1 · kind: These trades were made pursuant to a Rule 10b5-1 trading plan with pre-determined share amounts and prices. F3 · price: This transaction was executed in multiple trades at prices ranging from $40.00 to $40.245. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 13, 2017 Filed Jan 13, 2017 22:04 UTC |
Calcaterra Chris M.Chief Commercial Officer
|
Exercise / conversionCommon Stock | 3,723 | $7.28 | $27,084.83 |
DisclosureSEC source: 0001562180-17-000237 · primarydocument.xml · nonDerivative · entry 3 Calcaterra Chris M. · CIK 0001640771 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 243,723 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These trades were made pursuant to a Rule 10b5-1 trading plan with pre-determined share amounts and prices. Read SEC document |
| January 12, 2017 Filed Jan 13, 2017 17:04 UTC |
HARRISON RICHARD LCFO & Treasurer
|
Exercise / conversionStock Option (right to buy) · Derivative | 14,321 | $0.00 Strike: $7.28 | $0.00 |
DisclosureSEC source: 0001562180-17-000238 · primarydocument.xml · derivative · entry 6 HARRISON RICHARD L · CIK 0001186724 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,813 Underlying: Common Stock · 14,321 shares Expires 2024-07-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option has a four-year vesting schedule in which 25% vests on the first year anniversary date of the grant and the remainder vests equally for 36 months thereafter, such that the stock option vests in full on the four-year anniversary of the grant date. Read SEC document |
| January 12, 2017 Filed Jan 13, 2017 17:04 UTC |
HARRISON RICHARD LCFO & Treasurer
|
SaleCommon Stock | 14,321 | $40.00 | $572,840.00 |
DisclosureSEC source: 0001562180-17-000238 · primarydocument.xml · nonDerivative · entry 2 HARRISON RICHARD L · CIK 0001186724 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,388 F1 · kind: These trades were made pursuant to a Rule 10b5-1 trading plan with pre-determined share amounts and prices. F2 · price: This transaction was executed in multiple trades at prices ranging from $40.00 to $40.03. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 12, 2017 Filed Jan 13, 2017 17:04 UTC |
HARRISON RICHARD LCFO & Treasurer
|
Exercise / conversionCommon Stock | 14,321 | $7.28 | $104,185.28 |
DisclosureSEC source: 0001562180-17-000238 · primarydocument.xml · nonDerivative · entry 1 HARRISON RICHARD L · CIK 0001186724 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,709 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These trades were made pursuant to a Rule 10b5-1 trading plan with pre-determined share amounts and prices. Read SEC document |
| January 12, 2017 Filed Jan 13, 2017 22:04 UTC |
Calcaterra Chris M.Chief Commercial Officer
|
Exercise / conversionStock Options (Right to buy) · Derivative | 14,413 | $0.00 Strike: $7.28 | $0.00 |
DisclosureSEC source: 0001562180-17-000237 · primarydocument.xml · derivative · entry 5 Calcaterra Chris M. · CIK 0001640771 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,723 Underlying: Common Stock · 14,413 shares Expires 2024-07-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These trades were made pursuant to a Rule 10b5-1 trading plan with pre-determined share amounts and prices. F4 · derivative.exercise_date: This option, which represented the right to purchase a total of 110,000 shares, has a two-year vesting schedule in which 75% vested on July 10, 2015, the first anniversary of the grant date, and the remainder vested equally for 12 months thereafter, such that the stock option vested in full on July 31, 2016, the second anniversary of the grant date. Read SEC document |
| January 12, 2017 Filed Jan 13, 2017 22:04 UTC |
Calcaterra Chris M.Chief Commercial Officer
|
SaleCommon Stock | 14,413 | $40.00 | $576,520.00 |
DisclosureSEC source: 0001562180-17-000237 · primarydocument.xml · nonDerivative · entry 2 Calcaterra Chris M. · CIK 0001640771 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 240,000 F1 · kind: These trades were made pursuant to a Rule 10b5-1 trading plan with pre-determined share amounts and prices. F2 · price: This transaction was executed in multiple trades at prices ranging from $40.00 to $40.03. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 12, 2017 Filed Jan 13, 2017 22:04 UTC |
Calcaterra Chris M.Chief Commercial Officer
|
Exercise / conversionCommon Stock | 14,413 | $7.28 | $104,854.58 |
DisclosureSEC source: 0001562180-17-000237 · primarydocument.xml · nonDerivative · entry 1 Calcaterra Chris M. · CIK 0001640771 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 254,413 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These trades were made pursuant to a Rule 10b5-1 trading plan with pre-determined share amounts and prices. Read SEC document |
| January 09, 2017 Filed Jan 11, 2017 21:31 UTC |
Burns Thomas WilliamDirector · Chief Executive Officer
|
SaleCommon Stock | 40,000 | $37.60 | $1,504,000.00 |
DisclosureSEC source: 0001562180-17-000223 · primarydocument.xml · nonDerivative · entry 1 Burns Thomas William · CIK 0001644557 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Through the Burns Family Trust Disclosed balance after: 260,240 F1 · kind: These trades were made pursuant to a Rule 10b5-1 trading plan with pre-determined share amounts and prices. F2 · price: This transaction was executed in multiple trades at prices ranging from $37.50 to $37.83. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 852 shares acquired under the Company's Employee Stock Purchase Plan in December 2016. Read SEC document |
| January 09, 2017 Filed Jan 11, 2017 21:30 UTC |
Calcaterra Chris M.Chief Commercial Officer
|
Exercise / conversionStock Options (Right to buy) · Derivative | 20,000 | $0.00 Strike: $7.28 | $0.00 |
DisclosureSEC source: 0001562180-17-000222 · primarydocument.xml · derivative · entry 3 Calcaterra Chris M. · CIK 0001640771 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,136 Underlying: Common Stock · 20,000 shares Expires 2024-07-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These trades were made pursuant to a Rule 10b5-1 trading plan with pre-determined share amounts and prices. F3 · derivative.exercise_date: This option, which represented the right to purchase a total of 110,000 shares, has a two-year vesting schedule in which 75% vested on July 10, 2015, the first anniversary of the grant date, and the remainder vested equally for 12 months thereafter, such that the stock option vested in full on July 31, 2016, the second anniversary of the grant date. Read SEC document |
| January 09, 2017 Filed Jan 11, 2017 21:30 UTC |
Calcaterra Chris M.Chief Commercial Officer
|
SaleCommon Stock | 20,000 | $38.02 | $760,400.00 |
DisclosureSEC source: 0001562180-17-000222 · primarydocument.xml · nonDerivative · entry 2 Calcaterra Chris M. · CIK 0001640771 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 240,000 F1 · kind: These trades were made pursuant to a Rule 10b5-1 trading plan with pre-determined share amounts and prices. F2 · price: This transaction was executed in multiple trades at prices ranging from $38.00 to $38.11. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 09, 2017 Filed Jan 11, 2017 21:30 UTC |
Calcaterra Chris M.Chief Commercial Officer
|
Exercise / conversionCommon Stock | 20,000 | $7.28 | $145,500.00 |
DisclosureSEC source: 0001562180-17-000222 · primarydocument.xml · nonDerivative · entry 1 Calcaterra Chris M. · CIK 0001640771 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 260,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These trades were made pursuant to a Rule 10b5-1 trading plan with pre-determined share amounts and prices. Read SEC document |
| January 06, 2017 Filed Jan 9, 2017 16:00 UTC |
HARRISON RICHARD LCFO & Treasurer
|
Exercise / conversionStock Option (right to buy) · Derivative | 2,866 | $0.00 Strike: $7.28 | $0.00 |
DisclosureSEC source: 0001562180-17-000206 · primarydocument.xml · derivative · entry 9 HARRISON RICHARD L · CIK 0001186724 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,134 Underlying: Common Stock · 2,866 shares Expires 2024-07-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option has a four-year vesting schedule in which 25% vests on the first year anniversary date of the grant and the remainder vests equally for 36 months thereafter, such that the stock option vests in full on the four-year anniversary of the grant date. Read SEC document |
| January 06, 2017 Filed Jan 9, 2017 16:00 UTC |
HARRISON RICHARD LCFO & Treasurer
|
Exercise / conversionStock Option (right to buy) · Derivative | 16,500 | $0.00 Strike: $4.23 | $0.00 |
DisclosureSEC source: 0001562180-17-000206 · primarydocument.xml · derivative · entry 8 HARRISON RICHARD L · CIK 0001186724 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,500 Underlying: Common Stock · 16,500 shares Expires 2023-01-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option has a four-year vesting schedule in which 25% vests on the first year anniversary date of the grant and the remainder vests equally for 36 months thereafter, such that the stock option vests in full on the four-year anniversary of the grant date. Read SEC document |
| January 06, 2017 Filed Jan 9, 2017 16:00 UTC |
HARRISON RICHARD LCFO & Treasurer
|
Exercise / conversionStock Options (Right to buy) · Derivative | 1,268 | $0.00 Strike: $3.98 | $0.00 |
DisclosureSEC source: 0001562180-17-000206 · primarydocument.xml · derivative · entry 7 HARRISON RICHARD L · CIK 0001186724 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,268 shares Expires 2021-01-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These trades were made pursuant to a Rule 10b5-1 trading plan with pre-determined share amounts and prices. F4 · derivative.exercise_date: This option has a four-year vesting schedule in which 25% vests on the first year anniversary date of the grant and the remainder vests equally for 36 months thereafter, such that the stock option vests in full on the four-year anniversary of the grant date. Read SEC document |
| January 06, 2017 Filed Jan 9, 2017 16:00 UTC |
HARRISON RICHARD LCFO & Treasurer
|
SaleCommon Stock | 60 | $36.01 | $2,160.60 |
DisclosureSEC source: 0001562180-17-000206 · primarydocument.xml · nonDerivative · entry 5 HARRISON RICHARD L · CIK 0001186724 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,388 F1 · kind: These trades were made pursuant to a Rule 10b5-1 trading plan with pre-determined share amounts and prices. F3 · price: This transaction was executed in multiple trades at prices ranging from $36.00 to $36.06. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 06, 2017 Filed Jan 9, 2017 16:00 UTC |
HARRISON RICHARD LCFO & Treasurer
|
SaleCommon Stock | 20,574 | $35.58 | $731,981.77 |
DisclosureSEC source: 0001562180-17-000206 · primarydocument.xml · nonDerivative · entry 4 HARRISON RICHARD L · CIK 0001186724 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,448 F1 · kind: These trades were made pursuant to a Rule 10b5-1 trading plan with pre-determined share amounts and prices. F2 · price: This transaction was executed in multiple trades at prices ranging from $35.00 to $35.98. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| January 06, 2017 Filed Jan 9, 2017 16:00 UTC |
HARRISON RICHARD LCFO & Treasurer
|
Exercise / conversionCommon Stock | 2,866 | $7.28 | $20,850.15 |
DisclosureSEC source: 0001562180-17-000206 · primarydocument.xml · nonDerivative · entry 3 HARRISON RICHARD L · CIK 0001186724 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,022 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These trades were made pursuant to a Rule 10b5-1 trading plan with pre-determined share amounts and prices. Read SEC document |
| January 06, 2017 Filed Jan 9, 2017 16:00 UTC |
HARRISON RICHARD LCFO & Treasurer
|
Exercise / conversionCommon Stock | 16,500 | $4.23 | $69,712.50 |
DisclosureSEC source: 0001562180-17-000206 · primarydocument.xml · nonDerivative · entry 2 HARRISON RICHARD L · CIK 0001186724 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,156 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These trades were made pursuant to a Rule 10b5-1 trading plan with pre-determined share amounts and prices. Read SEC document |
| January 06, 2017 Filed Jan 9, 2017 16:00 UTC |
HARRISON RICHARD LCFO & Treasurer
|
Exercise / conversionCommon Stock | 1,268 | $3.98 | $5,040.30 |
DisclosureSEC source: 0001562180-17-000206 · primarydocument.xml · nonDerivative · entry 1 HARRISON RICHARD L · CIK 0001186724 · CFO & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,656 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These trades were made pursuant to a Rule 10b5-1 trading plan with pre-determined share amounts and prices. Read SEC document |
| December 14, 2016 Filed Dec 16, 2016 21:17 UTC |
Burns Thomas WilliamDirector · Chief Executive Officer
|
Exercise / conversionStock Options (Right to buy) · Derivative | 8,000 | $0.00 Strike: $1.25 | $0.00 |
DisclosureSEC source: 0001562180-16-003824 · primarydocument.xml · derivative · entry 6 Burns Thomas William · CIK 0001644557 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,000 Underlying: Common Stock · 8,000 shares Expires 2018-01-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option, which was granted on January 29, 2008, has a four-year vesting schedule in which 25% vested on the first year anniversary date of the grant and then vested equally for 36 months thereafter, such that the stock option was vested in full on the four-year anniversary of the grant date Read SEC document |
| December 14, 2016 Filed Dec 16, 2016 21:17 UTC |
Burns Thomas WilliamDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 8,000 | $1.25 | $10,000.00 |
DisclosureSEC source: 0001562180-16-003824 · primarydocument.xml · nonDerivative · entry 1 Burns Thomas William · CIK 0001644557 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Through the Burns Family Trust Disclosed balance after: 299,388 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: The amount now includes 1,388 shares that were previously reported as held directly by the reporting person, which were subsequently transferred to the Burns Family Trust. Read SEC document |
| December 07, 2016 Filed Dec 9, 2016 00:22 UTC |
Kliman Gilbert HDirector
|
OtherCommon Stock | 1,314 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-16-035167 · doc4.xml · nonDerivative · entry 4 Kliman Gilbert H · CIK 0001293171 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,083 F2 · kind: Represents pro rata in-kind distribution by IMP9 without consideration to its members in accordance with the terms of the InterWest Management Partners IX, LLC Operating Agreement. Includes 1,314 shares distributed to Kliman. Read SEC document |
| December 07, 2016 Filed Dec 9, 2016 00:22 UTC |
Kliman Gilbert HDirector
|
OtherCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-16-035167 · doc4.xml · nonDerivative · entry 3 Kliman Gilbert H · CIK 0001293171 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By InterWest Management Partners IX, LLC Disclosed balance after: 0 F2 · kind: Represents pro rata in-kind distribution by IMP9 without consideration to its members in accordance with the terms of the InterWest Management Partners IX, LLC Operating Agreement. Includes 1,314 shares distributed to Kliman. Read SEC document |
| December 07, 2016 Filed Dec 9, 2016 00:22 UTC |
Kliman Gilbert HDirector
|
OtherCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-16-035167 · doc4.xml · nonDerivative · entry 2 Kliman Gilbert H · CIK 0001293171 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By InterWest Management Partners IX, LLC Disclosed balance after: 10,000 F1 · kind: Represents pro rata in-kind distribution by InterWest Partners IX, LP ("IP9") without consideration to its limited and general partners in accordance with the terms of the InterWest Partners IX, LP Limited Partnership Agreement. Includes 10,000 shares distributed to InterWest Management Partners IX, LLC ("IMP9") its general partner. Read SEC document |
| December 07, 2016 Filed Dec 9, 2016 00:22 UTC |
Kliman Gilbert HDirector
|
OtherCommon Stock | 1,000,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-16-035167 · doc4.xml · nonDerivative · entry 1 Kliman Gilbert H · CIK 0001293171 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By InterWest Partners IX, LP Disclosed balance after: 1,018,362 F1 · kind: Represents pro rata in-kind distribution by InterWest Partners IX, LP ("IP9") without consideration to its limited and general partners in accordance with the terms of the InterWest Partners IX, LP Limited Partnership Agreement. Includes 10,000 shares distributed to InterWest Management Partners IX, LLC ("IMP9") its general partner. F3 · balance_after: The shares are owned by IP9. The general partner of IP9 is IMP9. Gianos, Oronsky, Kliman, Holmes, and Nasr have shared voting and investment control over shares owned by IP9, and disclaim beneficial ownership of those securities, except to the extent of their pecuniary interest therein. Read SEC document |
| November 17, 2016 Filed Nov 18, 2016 21:23 UTC |
LINK WILLIAM J PHDDirector
|
SaleCommon Stock | 30,000 | $33.78 | $1,013,400.00 |
DisclosureSEC source: 0001562180-16-003585 · primarydocument.xml · nonDerivative · entry 1 LINK WILLIAM J PHD · CIK 0001228684 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · see footnote Disclosed balance after: 87,695 F1 · price: This transaction was executed in multiple trades at prices ranging from $33.64 to $34.185. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F2 · ownership.nature: The shares are held by The Link Family Trust (the "Link Trust") for the benefit of William J. Link. William J. Link is a trustee of the Link Trust. The Reporting Person disclaims beneficial ownership of the shares except to the extent of his proportionate pecuniary interest therein. Read SEC document |
| November 15, 2016 Filed Nov 15, 2016 21:59 UTC |
Burns Thomas WilliamDirector · Chief Executive Officer
|
SaleCommon Stock | 10,000 | $34.03 | $340,300.00 |
DisclosureSEC source: 0001562180-16-003509 · primarydocument.xml · nonDerivative · entry 5 Burns Thomas William · CIK 0001644557 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Through the Burns Family Trust Disclosed balance after: 290,000 F1 · kind: These trades were made pursuant to a Rule 10b5-1 trading plan with pre-determined share amounts and prices. F4 · price: This transaction was executed in multiple trades at prices ranging from $34.00 to $34.17. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 14, 2016 Filed Nov 15, 2016 21:59 UTC |
Burns Thomas WilliamDirector · Chief Executive Officer
|
Exercise / conversionStock Options (Right to buy) · Derivative | 19,480 | $0.00 Strike: $1.93 | $0.00 |
DisclosureSEC source: 0001562180-16-003509 · primarydocument.xml · derivative · entry 12 Burns Thomas William · CIK 0001644557 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 19,480 shares Expires 2019-04-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: This option has a four-year vesting schedule in which 25% will vest on the first year anniversary date of the grant and then will vest equally for 36 months thereafter, such that the stock opotion is vested in full on the four-year anniversary of the grant date Read SEC document |
| November 14, 2016 Filed Nov 15, 2016 21:59 UTC |
Burns Thomas WilliamDirector · Chief Executive Officer
|
Exercise / conversionStock Options (Right to buy) · Derivative | 170,640 | $0.00 Strike: $1.65 | $0.00 |
DisclosureSEC source: 0001562180-16-003509 · primarydocument.xml · derivative · entry 11 Burns Thomas William · CIK 0001644557 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 170,640 shares Expires 2018-10-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: This option has a four-year vesting schedule in which 25% will vest on the first year anniversary date of the grant and then will vest equally for 36 months thereafter, such that the stock opotion is vested in full on the four-year anniversary of the grant date Read SEC document |
| November 14, 2016 Filed Nov 15, 2016 21:59 UTC |
Burns Thomas WilliamDirector · Chief Executive Officer
|
SaleCommon Stock | 3,605 | $34.21 | $123,327.05 |
DisclosureSEC source: 0001562180-16-003509 · primarydocument.xml · nonDerivative · entry 4 Burns Thomas William · CIK 0001644557 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Through the Burns Family Trust Disclosed balance after: 300,000 F1 · kind: These trades were made pursuant to a Rule 10b5-1 trading plan with pre-determined share amounts and prices. F3 · price: This transaction was executed in multiple trades at prices ranging from $34.15 to $34.26. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 14, 2016 Filed Nov 15, 2016 21:59 UTC |
Burns Thomas WilliamDirector · Chief Executive Officer
|
SaleCommon Stock | 186,515 | $33.65 | $6,276,229.75 |
DisclosureSEC source: 0001562180-16-003509 · primarydocument.xml · nonDerivative · entry 3 Burns Thomas William · CIK 0001644557 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Through the Burns Family Trust Disclosed balance after: 303,605 F1 · kind: These trades were made pursuant to a Rule 10b5-1 trading plan with pre-determined share amounts and prices. F2 · price: This transaction was executed in multiple trades at prices ranging from $33.14 to $34.13. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 14, 2016 Filed Nov 15, 2016 21:59 UTC |
Burns Thomas WilliamDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 19,480 | $1.93 | $37,499.00 |
DisclosureSEC source: 0001562180-16-003509 · primarydocument.xml · nonDerivative · entry 2 Burns Thomas William · CIK 0001644557 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Through the Burns Family Trust Disclosed balance after: 490,120 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 14, 2016 Filed Nov 15, 2016 21:59 UTC |
Burns Thomas WilliamDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 170,640 | $1.65 | $281,556.00 |
DisclosureSEC source: 0001562180-16-003509 · primarydocument.xml · nonDerivative · entry 1 Burns Thomas William · CIK 0001644557 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Through the Burns Family Trust Disclosed balance after: 470,640 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 24, 2016 Filed Oct 25, 2016 20:55 UTC |
Calcaterra Chris M.Chief Commercial Officer
|
Exercise / conversionStock Options (Right to buy) · Derivative | 20,000 | $0.00 Strike: $7.28 | $0.00 |
DisclosureSEC source: 0001562180-16-003274 · primarydocument.xml · derivative · entry 3 Calcaterra Chris M. · CIK 0001640771 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,136 Underlying: Common Stock · 20,000 shares Expires 2024-07-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These trades were made pursuant to a Rule 10b5-1 trading plan with pre-determined share amounts and prices. F3 · derivative.exercise_date: This option, which represented the right to purchase a total of 110,000 shares, has a two-year vesting schedule in which 75% vested on July 10, 2015, the first anniversary of the grant date, and the remainder vests equally for 12 months thereafter, such that the stock option will vest in full on July 31, 2016, the second anniversary of the grant date. Read SEC document |
| October 24, 2016 Filed Oct 25, 2016 20:55 UTC |
Calcaterra Chris M.Chief Commercial Officer
|
SaleCommon Stock | 20,000 | $36.01 | $720,200.00 |
DisclosureSEC source: 0001562180-16-003274 · primarydocument.xml · nonDerivative · entry 2 Calcaterra Chris M. · CIK 0001640771 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 240,000 F1 · kind: These trades were made pursuant to a Rule 10b5-1 trading plan with pre-determined share amounts and prices. F2 · price: This transaction was executed in multiple trades at prices ranging from $36.00 to $36.11. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| October 24, 2016 Filed Oct 25, 2016 20:55 UTC |
Calcaterra Chris M.Chief Commercial Officer
|
Exercise / conversionCommon Stock | 20,000 | $7.28 | $145,500.00 |
DisclosureSEC source: 0001562180-16-003274 · primarydocument.xml · nonDerivative · entry 1 Calcaterra Chris M. · CIK 0001640771 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 260,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These trades were made pursuant to a Rule 10b5-1 trading plan with pre-determined share amounts and prices. Read SEC document |
| October 20, 2016 Filed Oct 20, 2016 22:37 UTC |
Calcaterra Chris M.Chief Commercial Officer
|
Exercise / conversionStock Options (Right to buy) · Derivative | 40,000 | $0.00 Strike: $7.28 | $0.00 |
DisclosureSEC source: 0001562180-16-003252 · primarydocument.xml · derivative · entry 4 Calcaterra Chris M. · CIK 0001640771 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,136 Underlying: Common Stock · 40,000 shares Expires 2024-07-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These trades were made pursuant to a Rule 10b5-1 trading plan with pre-determined share amounts and prices. F4 · derivative.exercise_date: This option, which represented the right to purchase a total of 110,000 shares, has a two-year vesting schedule in which 75% vested on July 10, 2015, the first anniversary of the grant date, and the remainder vests equally for 12 months thereafter, such that the stock option will vest in full on July 31, 2016, the second anniversary of the grant date. Read SEC document |
| October 20, 2016 Filed Oct 20, 2016 22:37 UTC |
Calcaterra Chris M.Chief Commercial Officer
|
SaleCommon Stock | 3,000 | $34.20 | $102,600.00 |
DisclosureSEC source: 0001562180-16-003252 · primarydocument.xml · nonDerivative · entry 3 Calcaterra Chris M. · CIK 0001640771 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 240,000 F1 · kind: These trades were made pursuant to a Rule 10b5-1 trading plan with pre-determined share amounts and prices. F3 · price: This transaction was executed in multiple trades at prices ranging from $34.06 to $34.32. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| October 20, 2016 Filed Oct 20, 2016 22:37 UTC |
Calcaterra Chris M.Chief Commercial Officer
|
SaleCommon Stock | 37,000 | $34.81 | $1,287,970.00 |
DisclosureSEC source: 0001562180-16-003252 · primarydocument.xml · nonDerivative · entry 2 Calcaterra Chris M. · CIK 0001640771 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 243,000 F1 · kind: These trades were made pursuant to a Rule 10b5-1 trading plan with pre-determined share amounts and prices. F2 · price: This transaction was executed in multiple trades at prices ranging from $34.33 to $35.32. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| October 20, 2016 Filed Oct 20, 2016 22:37 UTC |
Calcaterra Chris M.Chief Commercial Officer
|
Exercise / conversionCommon Stock | 40,000 | $7.28 | $291,000.00 |
DisclosureSEC source: 0001562180-16-003252 · primarydocument.xml · nonDerivative · entry 1 Calcaterra Chris M. · CIK 0001640771 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 280,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These trades were made pursuant to a Rule 10b5-1 trading plan with pre-determined share amounts and prices. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.